Sekisui XenoTech Revenue and Competitors

Sekisui XenoTech is a global Contract Research Organization (CRO) serving clients with unparalleled experience and expertise in evaluating drug candidates, nutraceuticals, cosmetics, food additives and other compounds known as xenobiotics as substrates, inhibitors and inducers of cytochrome P450, UGT and other drug metabolizing enzymes, as well as drug transporters. We offer a variety of in vitro and in vivo safety assessment studies for drug candidate evaluation, as well as an extensive selection of products for drug metabolism research. Sekisui XenoTech's product selection includes a wide-range of high quality standard reagents, from subcellular fractions and hepatocytes to recombinant enzymes, substrates and metabolites. The company can also prepare and deliver custom-designed products and services in respnose to client requests. Sekisui XenoTech has extensive experience with the US FDA, EMA and MHLW governing bodies.